Zions Bancorporation, National Association’s Haemonetics HAE Stock Holding History

Zions Bancorporation, National Association’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$892K	Sell	11,890 -10,010	-46%	-$643K	0.05%	165
2026 Q1	$1.23M	Sell	21,900 -16,062	-42%	-$1.05M	0.08%	140
2025 Q4	$3.04M	Sell	37,962 -2,580	-6%	-$173K	0.14%	104
2025 Q3	$1.98M	Sell	40,542 -6,079	-13%	-$376K	0.1%	145
2025 Q2	$3.48M	Buy	46,621 +3,447	+8%	+$228K	0.19%	100
2025 Q1	$2.74M	Buy	+43,174	New	+$2.94M	0.17%	115

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zions Bancorporation, National Association's HAE Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Haemonetics (HAE) stake by 46% in Q2 2026, selling an estimated $643K and leaving 11,890 shares worth $892K. The position accounts for 0.05% of the portfolio, ranked #165.

Zions Bancorporation, National Association first reported a position in HAE in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.48M in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Zions Bancorporation, National Association held 11,890 shares of Haemonetics worth $892K as of Q2 2026.
Zions Bancorporation, National Association sold 10,010 Haemonetics shares in Q2 2026, an estimated $643K.
Haemonetics made up 0.05% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #165 holding.
Zions Bancorporation, National Association first reported a position in Haemonetics in Q1 2025 and has held it in 6 quarters since.
Zions Bancorporation, National Association's Haemonetics position peaked at $3.48M in Q2 2025.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.